Skip to main content
Clinical Trials/NL-OMON56275
NL-OMON56275CompletedNot Applicable

Effect of monomeric and oligomeric flavanols on exercise blood pressure and vascular function in healthy volunteers - Effect of monomeric and oligomeric flavanols on exercise blood pressure

niversiteit Maastricht0 sites41 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
41

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • 1. Healthy men and women with normal to high-normal resting blood pressure
  • (systolic blood pressure (SBP) 120 - 139 mm Hg and diastolic blood pressure 80
  • - 89 mm Hg).
  • 2. Age 35 - 65 years
  • 3. BMI 20 - 32 kg/m^2
  • 4. Hypertensive response to maximal exercise test defined as SBP >= 200 mm Hg
  • (men) and >= 180 mm Hg (women).

Exclusion Criteria

  • 1. Active engagement in the weight loss programs, also including slimming
  • 2. Active smoking or abstinence from smoking for less than one year.
  • 3. Use of medications that reduce BP and/or can potentially influence other
  • study outcomes (ACE-inhibitors, angiotensin receptor blockers, diuretics,
  • painkillers, etc).
  • 4. Intake of polyphenol-containing supplements for two month before and during
  • the whole course of the study.
  • 5. History of diabetes, cardiovascular, respiratory, renal, gastrointestinal,
  • hepatic or other diseases and conditions, which potentially can compromise
  • participation in this study.
  • 6. Intense sporting (>10 h/week) and/or participation in the competition at the
  • professional level.
  • 7. Pregnancy or breastfeeding.
  • 8. Participation in a clinical trial within four weeks prior to inclusion into
  • this study.
  • 9. Vaccination against Covid-19 within two months before the
  • screening/randomization visit or expected vaccination against Covid-19 during

Investigators

Similar Trials